urothelium

Urothelium is composed of multiple layers: a basal cell layer, intermediate cells, and superficial 'umbrella' cells. Umbrella cells are large, often binucleate, and have specialized apical plaques containing uroplakin proteins that form a rigid, impermeable membrane preventing urine (hypertonic, acidic, urea-laden) from damaging underlying tissue. Tight junctions between umbrella cells further reinforce this barrier, which is critical for maintaining the osmotic gradient of the kidney and protecting deeper tissues from toxic urine components.

Urothelium exhibits remarkable elasticity, allowing it to change shape from cuboidal (when the bladder is empty) to squamous-like (when distended) without losing barrier integrity—a feature enabled by asymmetric unit membranes and cytoplasmic plaque reserves that unfold during stretch.

Clinically, urothelium is significant because it is the site of origin for urothelial carcinoma (transitional cell carcinoma), accounting for ~90% of bladder cancers. Risk factors include smoking, aromatic amine exposure (e.g., in dye/rubber industries), chronic cyclophosphamide use, and Schistosoma haematobium infection (though the latter more classically causes squamous cell carcinoma due to chronic irritation and metaplasia). Urothelial carcinoma can be papillary or flat (carcinoma in situ), and can occur anywhere along the urothelial-lined tract (renal pelvis, ureters, bladder, proximal urethra), often presenting with painless hematuria. Field cancerization effect explains multifocal or recurrent tumors along the tract.

Understanding urothelium's structure also matters for interpreting cystoscopic and pathologic findings, as well as for understanding conditions like interstitial cystitis, where urothelial barrier dysfunction (reduced glycosaminoglycan layer) is implicated in bladder pain syndrome.